- PROFESSOR Neurology
American Board of Psychiatry and Neurology
MD, State University of Guadalajara Medical School
Residency, Internal Medicine
* Elmhurst Hospital Center *
Albert Einstein College of Medicine
Internship, 5TH Pathway
* Elmhurst Hospital Center *
Fellowship, HEADACHE UNIT
* Montefiore Medical Center - GME *
Lawrence C. Newman, MD, FAHS, FAAN- Is Professor of Neurology at the Icahn School of Medicine and Director of the Roosevelt Hospital Center Headache Institute. He is a Diplomat of the American Board of Psychiatry and Neurology, being Board Certified in Neurology. He has also received sub-specialty certification in Headache Medicine by the United Council for Neurological Subspecialties.
Dr. Newman is a member of the American Academy of Neurology, National Headache Foundation, and the International Headache Society. He is a Fellow of the American Academy of Neurology and the Headache Society (AHS) and is currently Executive the President of the AHS.
Dr. Newman is the Co-Editor for the journal Current Pain and Headache Reports, and is an Editorial Board Member of the journal Headache Currents. He is an ad-hoc reviewer for the journals Headache, Cephalalgia, and Neurology.
Dr. Newman was a resident and chief resident in Neurology at the Albert Einstein College of Medicine in the Bronx, New York, and completed a formal Headache Fellowship at the Montefiore Headache Unit. He was the Director of the Montefiore Headache Unit from 1996-1997, before founding the Headache Institute at Roosevelt.
Dr. Newman has lectured on a variety of topics both nationally and internationally, and recently received the Leonard L. Lovshin Lectureship Award from the Cleveland Clinic Foundation. He has authored or co-authored 2 books, 35 original publications, 6 monographs, 33 book chapters, and presented 23 scientific papers at major meetings. He is the Co-editor of the textbook series What Do I Do Now?, published by Oxford University Press.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Newman during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Teva Pharmaceutical Industries Ltd.
Scientific Advisory Board:
- Depomed; Teva Pharmaceutical Industries Ltd.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- Allergan, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.